Supernus Pharmaceuticals Set to Present at Bank of America CNS Therapeutics Virtual Conference

miércoles, 3 de diciembre de 2025, 4:07 pm ET1 min de lectura
SUPN--

Supernus Pharmaceuticals announced that Jack A. Khattar, President and CEO, will present at the Bank of America Securities 2025 CNS Therapeutics Virtual Conference on December 8, 2025. The presentation will be available via live audio webcast on the company's website. Supernus Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing products for central nervous system diseases.

Supernus Pharmaceuticals Set to Present at Bank of America CNS Therapeutics Virtual Conference

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios